Business Context and Reporting Period
This Form 8-K was filed by Ipsidy Inc. (trading symbol: AUID) on August 23, 2021. The filing reports the entry into a material definitive agreement regarding a public offering of common stock. The company is an emerging growth company incorporated in Delaware.
Key Financial Metrics and Transaction Details
- Offering Size: 1,428,571 shares of common stock (Underwritten Shares).
- Offering Price: $7.00 per share.
- Net Proceeds: $8,900,000 (after underwriting discounts and expenses).
- Over-Allotment Option: Underwriters granted a 45-day option to purchase up to 214,285 additional shares.
- Representative's Warrants: 64,286 warrants issued to underwriters (4.5% of total shares), exercisable at $8.75 per share for 4.5 years starting February 23, 2022.
- Use of Proceeds: Software product/platform development, artificial intelligence, business development, sales/marketing expansion, and working capital.
Material Changes
The filing does not provide comparative financial data (revenue, profit, or cash flow) as it is a current report regarding a specific transaction rather than a periodic financial statement. The primary material change is the capitalization event resulting from the underwriting agreement signed on August 23, 2021, with an expected closing date of August 26, 2021.
Outlook, Risks, and Unusual Items
- Lock-Up Agreement: The Company, its officers, and directors agreed to a 180-day lock-up period from the effective date of the registration statement, restricting the sale of common stock or convertible securities without the Representative's consent.
- Strategic Focus: Management intends to deploy capital toward artificial intelligence and platform development.
- Legal Disclaimer: Representations and warranties in the Underwriting Agreement are not intended as a source of factual information for the public; investors should refer to other SEC filings for current state of affairs.
Investor Verification Checklist
- Verify the final closing date and actual net proceeds received (expected August 26, 2021).
- Confirm whether the over-allotment option was exercised by the underwriters.
- Review the Company's Form S-1 (File No. 333-257453) for detailed risk factors and use of proceeds.
- Monitor compliance with the 180-day lock-up agreement for insiders.
- Check subsequent filings for the actual deployment of funds into AI and software development.